X0306 4/A 2012-06-29 2012-07-02 0 0001053369 ELITE PHARMACEUTICALS INC /NV/ ELTP 0001465825 NIGALAYE ASHOK G C/O EPIC PHARMA, LLC 227-15 NORTH CONDUIT AVENUE LAURELTON NY 11413 1 1 1 0 Chief Scientific Officer Series E Convertible Preferred Stock 0.0244 2012-06-29 4 A 0 187.5 1000 A 2012-06-29 Common Stock 7684427 1937.5 I see footnote Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer. The grant of the Series E Preferred Stock was approved by the issuer's board of directors on March 13, 2009. This amendment is filed because the transaction was previously erroneously described as a Purchase. N/A Ashok Nigalaye 2012-08-09